Lataa…
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Neutralizing antibodies elicited by prior infection or vaccination are likely to be key for future protection of individuals and populations against SARS-CoV-2. Moreover, passively administered antibodies are among the most promising therapeutic and prophylactic anti-SARS-CoV-2 agents. However, the...
Päätekijät: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Aineistotyyppi: | Online Artikkeli Teksti |
Kieli: | English |
Julkaistu: |
eLife Sciences Publications, Ltd
2020
|
Aiheet: | |
Linkit: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723407/ https://www.ncbi.nlm.nih.gov/pubmed/33112236 http://dx.doi.org/10.7554/eLife.61312 |